91 related articles for article (PubMed ID: 31412643)
1. Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis.
Lu W; Li N; Liao F
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31412643
[TBL] [Abstract][Full Text] [Related]
2. Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients.
Li X; Wang Q; Wu Z; Zheng J; Ji L
Comput Math Methods Med; 2022; 2022():5113447. PubMed ID: 35047055
[TBL] [Abstract][Full Text] [Related]
3. GSK2126458 has the potential to inhibit the proliferation of pancreatic cancer uncovered by bioinformatics analysis and pharmacological experiments.
Feng Y; Jiang Y; Hao F
J Transl Med; 2021 Aug; 19(1):373. PubMed ID: 34461940
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors.
Posta M; Győrffy B
Clin Transl Sci; 2023 Aug; 16(8):1479-1491. PubMed ID: 37260110
[TBL] [Abstract][Full Text] [Related]
5. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer.
Caxali GH; Brugnerotto L; Aal MCE; Castro CFB; Delella FK
Cancer Genomics Proteomics; 2023; 20(5):487-499. PubMed ID: 37643780
[TBL] [Abstract][Full Text] [Related]
6. Identification of key biomarkers and associated pathways of pancreatic cancer using integrated transcriptomic and gene network analysis.
Rambabu M; Konageni N; Vasudevan K; Dasegowda KR; Gokul A; Jayanthi S; Rohini K
Saudi J Biol Sci; 2023 Nov; 30(11):103819. PubMed ID: 37860809
[TBL] [Abstract][Full Text] [Related]
7. Leucine rich repeat LGI family member 3: Integrative analyses support its prognostic association with pancreatic adenocarcinoma.
Yun HY
Medicine (Baltimore); 2024 Feb; 103(8):e37183. PubMed ID: 38394487
[TBL] [Abstract][Full Text] [Related]
8. Exploring protein profiles and hub genes in ameloblastoma.
Sanguansin S; Kengkarn S; Klongnoi B; Chujan S; Roytrakul S; Kitkumthorn N
Biomed Rep; 2024 Apr; 20(4):64. PubMed ID: 38476605
[TBL] [Abstract][Full Text] [Related]
9. Identification of hyper-rewired genomic stress non-oncogene addiction genes across 15 cancer types.
Hjaltelin JX; Izarzugaza JMG; Jensen LJ; Russo F; Westergaard D; Brunak S
NPJ Syst Biol Appl; 2019; 5():27. PubMed ID: 31396397
[TBL] [Abstract][Full Text] [Related]
10. InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment.
Koido M; Tani Y; Tsukahara S; Okamoto Y; Tomida A
Oncotarget; 2018 Jun; 9(49):29097-29111. PubMed ID: 30018738
[TBL] [Abstract][Full Text] [Related]
11. Aberration hubs in protein interaction networks highlight actionable targets in cancer.
Karimzadeh M; Jandaghi P; Papadakis AI; Trainor S; Rung J; Gonzàlez-Porta M; Scelo G; Vasudev NS; Brazma A; Huang S; Banks RE; Lathrop M; Najafabadi HS; Riazalhosseini Y
Oncotarget; 2018 May; 9(38):25166-25180. PubMed ID: 29861861
[TBL] [Abstract][Full Text] [Related]
12. Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
PLOS ONE Editors
PLoS One; 2023; 18(11):e0294622. PubMed ID: 37967142
[No Abstract] [Full Text] [Related]
13. Extracellular matrix is the main targeted environment in early stage of pancreatic ductal adenocarcinoma.
Mansouri V; Arjmand B; Hamzeloo-Moghadam M; Razzaghi Z; Ahmadzadeh A; Ehsani Ardakani MJ; Mohamoud Robati R
Gastroenterol Hepatol Bed Bench; 2023; 16(4):401-407. PubMed ID: 38313356
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.
Zhang B; Li J; Wang Y; Liu X; Yang X; Liao Z; Deng S; Deng Y; Zhou Z; Tian Y; Wei W; Meng J; Hu Y; Wan C; Zhang Z; Huang F; Wen L; Wu B; Sun Y; Li Y; Yang K
Cell Death Differ; 2024 Mar; 31(3):309-321. PubMed ID: 38287116
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of key biomarkers for bladder cancer.
Liu W; Xu Y; Bai S; Liao L
Biomed Rep; 2023 Feb; 18(2):14. PubMed ID: 36643693
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer.
Wang N; Gu Y; Li L; Chi J; Liu X; Xiong Y; Zhong C
J Inflamm Res; 2022; 15():3477-3499. PubMed ID: 35726216
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis.
Feng J; Wei T; Cui X; Wei R; Hong T
Chronic Dis Transl Med; 2021 Dec; 7(4):276-286. PubMed ID: 34786546
[TBL] [Abstract][Full Text] [Related]
18. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.
Kisling SG; Natarajan G; Pothuraju R; Shah A; Batra SK; Kaur S
Cancer Metastasis Rev; 2021 Sep; 40(3):721-738. PubMed ID: 34591244
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Tumor Cytolysis by NK Cells in Combination With a Pan-HDAC Inhibitor, Panobinostat.
Afolabi LO; Bi J; Li X; Adeshakin AO; Adeshakin FO; Wu H; Yan D; Chen L; Wan X
Front Immunol; 2021; 12():701671. PubMed ID: 34531855
[TBL] [Abstract][Full Text] [Related]
20. Expression and Role of Heparan Sulfated Proteoglycans in Pancreatic Cancer.
Furini S; Falciani C
Front Oncol; 2021; 11():695858. PubMed ID: 34249755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
